Researchers at the School of Medicine have identified a novel enzyme involved in building the cell wall of Cryptococcus neoformans, a fungus that causes lung infections and potentially deadly cases of meningitis, primarily ...
Cell & Microbiology
Jul 9, 2024
0
0
Pseudomonas aeruginosa—an environmental bacteria that can cause devastating multidrug-resistant infections, particularly in people with underlying lung conditions—evolved rapidly and then spread globally over the last ...
Evolution
Jul 4, 2024
0
80
Bacterial biofilm infections are among the leading causes of morbidity and mortality among patients with cystic fibrosis or those with weakened immune systems. Treatment for biofilm infections usually entails intensive antibiotic ...
Bio & Medicine
Jun 11, 2024
0
23
How do pathogens invade the lungs? Using human lung microtissues, a team at the Biozentrum of the University of Basel has uncovered the strategy used by a dangerous pathogen. The bacterium targets specific lung cells and ...
Cell & Microbiology
Jun 10, 2024
0
1
Airway hillocks are mysterious, flat-topped structures that were only recently identified within regular lung tissue, and their role in airway biology and pathology has previously been unknown.
Cell & Microbiology
May 1, 2024
0
72
Scientists have discovered a target for the development of a drug to combat a bacterium that can cause chronic lung infection in hospitalized patients, immunocompromised individuals and people with cystic fibrosis.
Cell & Microbiology
Apr 10, 2024
0
1
Scientists have engineered a living material resembling human phlegm, which will help them to better understand how a certain kind of infection develops on the lungs of patients with cystic fibrosis.
Cell & Microbiology
Nov 21, 2023
0
14
Therapy for the dangerous infectious disease of tuberculosis faces the challenge of pathogens frequently being resistant to several common antibiotics. Researchers of Karlsruhe Institute of Technology (KIT) have now developed ...
Bio & Medicine
Jun 27, 2023
0
27
University of Sydney scientists have discovered a protein in the lung that blocks SARS-CoV-2 infection and forms a natural protective barrier in the human body.
Cell & Microbiology
Feb 9, 2023
0
525
Researchers have designed the first "living medicine" to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria that is naturally resistant to many types of antibiotics and is a common source ...
Cell & Microbiology
Jan 19, 2023
1
75
